The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
Open accessAbstract
Starvation blocks the actions of growth hormone (GH) and inhibits growth through mechanisms that are not well understood. In this report, we demonstrate that fibroblast growth factor 21 (FGF21), a hormone induced by fasting, causes GH resistance. In liver, FGF21 reduces concentrations of the active form of signal transducer and activator of transcription 5 (STAT5), a major mediator of GH actions, and causes corresponding decreases in the expression of its target genes, including insulin-like growth factor 1 (IGF-1). FGF21 also induces hepatic expression of IGF-1 binding protein 1 and suppressor of cytokine signaling 2, which blunt GH signaling. Chronic exposure to FGF21 markedly inhibits growth in mice. These data suggest a central role for FGF21 in inhibiting growth as part of its broader role in inducing the adaptive response to starvation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the observation that Fgf21 causes resistance to GH (Inagaki et al, 2008)”
From Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency (2018) · cites this paper as Inagaki et al, 2008
In the citing paper
“Given that high plasma concentrations of FGF21 have been observed to reduce growth hormone signaling, resulting in a marked growth defect (Inagaki et al, 2008)”
From Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency (2018) · cites this paper as Inagaki et al, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Nutritional Regulation of the Insulin-Like Growth Factors*
Thissen, J., Ketelslegers, J., & Underwood, L. E. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-1-80 · Cited by 1,575
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationBadman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J., STANNARD, B. S., Butler, A. A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,418
Teglund, S., McKay, C., Schuetz, E. G., van Deursen, J. M., Stravopodis, D. J., Wang, D., Brown, M. P., Bodner, S. M., Grosveld, G. C., & Ihle, J. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81444-0 · Cited by 1,266
βKlotho is required for metabolic activity of fibroblast growth factor 21
Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M., & Kuro-o, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701600104 · Cited by 617
Self-citationBinding proteins for the insulin-like growth factors: Structure, regulation and function
Baxter, R. C., & Martin, J. L. (1989) · Progress in Growth Factor Research · doi:10.1016/0955-2235(89)90041-0 · Cited by 568
Effect of Growth Hormone on Carbohydrate and Lipid Metabolism
Davidson, M. B. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-115 · Cited by 567
Guo, S., Rena, G., Cichy, S. B., He, X., Cohen, P., & Unterman, T. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17184 · Cited by 540
Gigantism in mice lacking suppressor of cytokine signalling-2
Metcalf, D., Greenhalgh, C. J., Viney, E. M., Willson, T. A., Starr, R., Nicola, N. A., Hilton, D. J., & Alexander, W. S. (2000) · Nature · doi:10.1038/35016611 · Cited by 490
PPARα is a key regulator of hepatic FGF21
Lundåsen, T., Hunt, M., Nilsson, L.-M., Sanyal, S., Angelin, B., Alexson, S., & Rudling, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.068 · Cited by 361
Suzuki, M., Uehara, Y., Motomura-Matsuzaka, K., Oki, J., Koyama, Y., Kimura, M., Asada, M., Komi-Kuramochi, A., Oka, S., & Toru, T. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0313 · Cited by 345
Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
LeRoith, D., & Yakar, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0427 · Cited by 344
The role of STAT proteins in growth hormone signaling
Herrington, J., Smit, L. S., Schwartz, J., & Carter-Su, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203526 · Cited by 289
SOCS2 negatively regulates growth hormone action in vitro and in vivo
Greenhalgh, C. J., Rico-Bautista, E., Lorentzon, M., Thaus, A. L., Morgan, P. O., Willson, T. A., Zervoudakis, P., Metcalf, D., Street, I. P., Nicola, N. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522710 · Cited by 259
Hormonal and Nutritional Regulation of IGF-I and Its Binding Proteins
Underwood, L. E., Thissen, J.-P., Lemozy, S., Ketelslegers, J.-M., & Clemmons, D. R. (2008) · Hormone Research · doi:10.1159/000184187 · Cited by 225
Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions
Rico-Bautista, E., Flores‐Morales, A., & Fernández‐Pérez, L. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.008 · Cited by 211
Lowe, W. L., Adamo, M. L., Werner, H., Roberts, C. T., & LeRoith, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114207 · Cited by 208
Bornfeldt, K., Arnqvist, H. J., Enberg, B., Mathews, L. S., & Norstedt, G. (1989) · Journal of Endocrinology · doi:10.1677/joe.0.1220651 · Cited by 173
STAT5b Is Required for GH-Induced Liver Igf-I Gene Expression
Davey, H. W., Xie, T., McLachlan, M. J., Wilkins, R. J., Waxman, D. J., & Grattan, D. R. (2001) · Endocrinology · doi:10.1210/endo.142.9.8400 · Cited by 169
Greenhalgh, C. J., Bertolino, P., Asa, S. L., Metcalf, D., Corbin, J. E., Adams, T. E., Davey, H. W., Nicola, N. A., Hilton, D. J., & Alexander, W. S. (2002) · Molecular Endocrinology · doi:10.1210/me.16.6.1394 · Cited by 166
Maes, M. H. J., Underwood, L. E., & Ketelslegers, J. M. (1983) · Journal of Endocrinology · doi:10.1677/joe.0.0970243 · Cited by 153
Emler, C. A., & Schalch, P. (1987) · Endocrinology · doi:10.1210/endo-120-2-832 · Cited by 137
Role of Insulin-Like Growth Factor Iin Maintaining Normal Glucose Homeostasis
Clemmons, D. R. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080763 · Cited by 132
STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver
Davey, H. W., McLachlan, M. J., Wilkins, R. J., Hilton, D. J., & Adams, T. E. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00175-6 · Cited by 115
Holloway, M. G., Cui, Y., Laz, E. V., Hosui, A., Hennighausen, L. G., & Waxman, D. J. (2007) · Endocrinology · doi:10.1210/en.2006-1419 · Cited by 109
In vivo regulation of growth hormone-stimulated gene transcription by STAT5b
Woelfle, J., & Rotwein, P. S. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00389.2003 · Cited by 93
Ruotolo, G., Båvenholm, P., Brismar, K., Efendić, S., Ericsson, C.-G., Fairé, U. D., Nilsson, J., & Hamsten, A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00591-4 · Cited by 87
Impairment of Liver GH Receptor Signaling by Fasting
Beauloye, V., Willems, B., de Coninck, V., Frank, S. J., Edery, M., & Thissen, J. (2002) · Endocrinology · doi:10.1210/endo.143.3.8692 · Cited by 77
Minireview: Insights from Insulin-Like Growth Factor Binding Protein Transgenic Mice
Silha, J. V., & Murphy, L. J. (2002) · Endocrinology · doi:10.1210/en.2002-220116 · Cited by 68
Seneviratne, C. K., Luo, J., & Murphy, L. J. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-8-1199 · Cited by 68
Murphy, L. J., Seneviratne, C. K., MOREIRA, P., & Reid, R. E. (1991) · Endocrinology · doi:10.1210/endo-128-2-689 · Cited by 64
LeRoith, D., & NISSLEY, P. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24228 · Cited by 52
Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b
Shipley, J. M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.020 · Cited by 49
Ono, M., Chia, D. J., Merino-Martinez, R., Flores‐Morales, A., Unterman, T. G., & Rotwein, P. S. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0543 · Cited by 36
Age-Dependent Regulation of the Acid-Labile Subunit in Response to Fasting-Refeeding in Rats
Kong, S., Baxter, R. C., & Delhanty, P. J. D. (2002) · Endocrinology · doi:10.1210/en.2002-220527 · Cited by 15
Flagged first, then by citations
Cited by
Sorted by citations
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130024 · Cited by 2,401
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Self-citationFGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885
Metadata
- Authors
- Inagaki, T., Lin, V. Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., & Kliewer, S. A.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Howard Hughes Medical Institute (US)
- New York University (US)
- Corresponding author
- Kliewer, Steven A.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 8
- Issue
- 1
- Pages
- 77-83
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC2575072
- OpenAlex
- W2114836473
- Cited by
- 409
- References
- 37
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 22 · 2023: 12 · 2022: 21 · 2021: 35 · 2020: 22 · 2019: 27 · 2018: 22 · 2017: 18 · 2016: 31 · 2015: 44 · 2014: 44 · 2013: 19 · 2012: 26
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of General Medical Sciences (RL1GM084436)
- National Institute of Diabetes and Digestive and Kidney Diseases (PL1DK081182)
- National Institute of Dental and Craniofacial Research (DE13686, R01DE013686)
- National Center for Research Resources (P20RR020691)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- FGF21, growth hormone signaling, fasting, starvation, growth inhibition, STAT5, insulin-like growth factor I, SOCS2, hepatic gene expression
- MeSH terms
- Adaptation, Physiological, Animals, Fasting, Fibroblast Growth Factors, Growth, Liver, Growth Hormone, Starvation, Signal Transduction, STAT5 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
